Cargando…
Infliximab for Idiopathic Deep Cutaneous Vasculitis Refractory to Cyclophosphamide
Cutaneous vasculitis can be classified as primary or idiopathic; or secondary, when it presents as a manifestation of connective tissue diseases, infections, drug reactions or malignancies. Although most of the idiopathic cases are self-limited and responsive to supportive measures and nonsteroidal...
Autores principales: | Schafranski, Marcelo Derbli, Campanari, Giuliano Doretto |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003994/ https://www.ncbi.nlm.nih.gov/pubmed/21188210 http://dx.doi.org/10.1155/2010/951850 |
Ejemplares similares
-
Simultaneous development of sarcoidosis and cutaneous vasculitis in a patient with refractory Crohn’s disease during infliximab therapy
por: Numakura, Tadahisa, et al.
Publicado: (2016) -
Action of anti-TNF-α drugs on the progression of Alzheimer's
disease: A case report
por: Camargo, Carlos Henrique Ferreira, et al.
Publicado: (2015) -
Association of aortic and main left coronary aneurysms with severe aortic insufficiency in Takayasu’s arteritis
por: Schafranski, Marcelo Derbli, et al.
Publicado: (2011) -
Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)
por: Salehzadeh, Farhad, et al.
Publicado: (2019) -
A Case Series of Refractory Cutaneous Sarcoidosis Successfully Treated with Infliximab
por: Tuchinda, Papapit, et al.
Publicado: (2012)